Summary.-It has been reported that lymphocytes from cancer patients give positive responses to PPD, myelin basic protein, tumour basic protein, and certain histone fractions in the MEM test. The underlying mechanisms of the MEM test are poorly understood, but it is widely assumed that it detects immunological sensitization to specific antigenic determinants. The cross-reactivity experienced is interpreted as indicating shared antigenicity. Since all the stimulatory proteins are strongly basic we investigated an alternative explanation that responsiveness is a function of electrical charge by comparing the known stimulatory proteins in the MEM test with two others of similar basicity: lysozyme and cytochrome-C. We obtained highly significant stimulation with PPD, tryptophane peptide of myelin, and tumour basic protein using Mantoux + cancer patients, but found no response to other basic proteins. We failed to confirm the reported activity of histone F2a. Our results indicate that basicity alone is insufficient to elicit response, and strengthens the concept that the MEM test is measuring sensitization to the determinants shared by myelin and tumour basic protein.
THE macrophage electrophoretic mobility (MEM) test was first suggested as being useful in the diagnosis of human malignant disease by Field and Caspary (1970) , and multiple sclerosis (MS) by Field, Shenton and Joyce (1974) . These reports encouraged interest in its underlying mechanisms. The test is similar in principle to the better understood macrophage migration inhibition (MMI) assay, in which sensitized lymphocytes are stimulated by the appropriate antigen to release a factor (MIF) inhibiting macrophage migration. A similar immunological basis for the two tests is suggested by their capacity to detect lymphocyte sensitization to tumour basic protein in cancer patients (Hughes and Paty, 1971; Light, Preece and Waldron, 1975) . The MEM test, however, is credited with greater sensitivity.
The MEM test has demonstrated sensitization to a variety of antigens, including the purified protein derivative of the tuberculin bacillus (PPD) (Carnegie et al., 1973b) fractionated thyroglobulin in Graves' disease , saline extract of muscle and peripheral human nerve in myasthenia gravis , encephalitogenic factor, and human sciatic nerve basic protein in neurological disease (Field, Caspary and Smith, 1973) . However, despite the apparent specificity of these responses, tumour basic protein will give a positive MEM test with lymphocytes from patients suffering from demyelinating disease, and myelin basic protein will evoke responses with lymphocytes from patients with malignant disease. Furthermore, patients with autoimmune diseases such as ulcerative colitis and systemic lupus erythematosus show sensitization to a variety of unrelated antigens, and to encephalitogenic factor and tumour basic protein (Field, 1973 range between 6-6 and 7-2, whereas lysozyme has a pl of 11-0, and cytochrome-C of 10-5 (Lehninger, 1972) . Preparations of tumour basic protein contain more than one component on gel electrophoresis. However, the component containing the antigenic properties has an electrophoretic mobility 0 85 that of cytochrome-C on polyacrylamide gel electrophoresis (Caspary, 1973) . The pls of tumour basic protein, and myelin basic protein have yet to be assessed, but their electrophoretic mobilities relative to cytochrome-C, and their elution characteristics from CM-cellulose suggest that tumour basic protein is strongly basic, but not as extremely basic as myelin basic protein cytochrome-C, and its electrophoretic mobility is very similar to that of histone (Deibler, Martenson and Kies, 1972) . Incubation of lymphocytes and macrophages.-Incubations were performed according to the MOD-MEM split incubation technique of Pritchard et al. (1973) with one major modification. In our protocol, control supernatants wTere reconstituted with a concentration of antigen equivalent to the experimental supernatant, prior to incubation with the macrophages. One ml of a lymphocyte suspension, containing 106 cells, was incubated with 30 [kg of the appropriate antigen in a final volume of 1-2 ml for 90 min at 23°C in the experimental tube, and the lymphocytes were incubated for a similar period without antigen in the control. The cells were spun at 250gq for 10 min, the supernatants pipetted off, the control supernatant reconstituted with antigen, and then stored at -80°C. Five ml of the macrophage suspension was incubated with one ml of the experimental and control supernatants, respectively, for 90 min at 37°C. By separating the incubation of lymphocytes from that of the macrophages any possibility of stimulation arising from mixed lymphocyte reactions is obviated. The methodology is presented diagrammatically in Fig. 1 .
Cytopheromneter.-Measurements of macrophage electrophoretic mobility were performed in a cytopherometer (Ranks Bros., Cambridge, England). The cylindrical capillary chamber was employed, and maintained at a constant temperature of 23°C. A potential difference of 40 V was applied across the electrodes giving a current of 2 mA in PBS. Blacked platinum electrodes were used. Measurements.-Following incubation of the macrophages with the lymphocyteantigen supernatants, they were transferred, suspended in the incubation mixture, to the cytopherometer. Cells were selected from the heterogeneous macrophage population on the basis of appearance. Only cells with 2-4 oil droplets were followed, adhering to the criteria defined by Shenton, Hughes and Field (1973) . The time taken for the selected cell to traverse 32 ,u in the stationary layer was recorded using a stopwatch. Each cell was timed in both directions by reversing the polarity, and readings discarded if there was more than 10% discrepancy between the members of each pair (Pritchard et al., 1972) .
The response of the macrophages was checked in each experiment by the inclusion of a supernatant obtained by incubating PPD with a PPD-+ donor's lymphocytes as a positive control. The 00 reduction in mobility was calculated according to the formula used by Johns et al. (1973) found that histone fraction 2, subfractions a1 and a2, produced considerable slowing. Indirect evidence, in support of Johns' data, has been recently provided by Sabolovic et al. (1975) who showed that massive agglutination of cancer patients' lymphocytes occurred in the presence of histone fraction 2a1, but that lymphocytes from normal volunteers were unaffected. However, conflicting information has been published by Schmid et al. (1974) who were unable to demonstrate immunological cross-reactivity between histone fractions 1, 2a1, 2a2, and 3 to antibodies directed against human myelin basic protein. Although the lack of crossreactivity of the histone fractions to antibodies directed against myelin basic protein supports our findings, it has been argued that T-cell receptors may not recognize the same determinants as B-cell immunoglobulins (Diener and Langman, 1975) . Since MIF/MEM activity is considered a T-cell response, this cannot be cited as definitive proof of the absence of shared determinants. McDermott et al. (1974) used unfrac- tionated calf thymus histone as a control basic protein in their cellular affinity studies, and reported that it was unable to deplete lymphocytes responsive to tumour basic protein and myelin basic protein. More compelling evidence for a lack of cross-reactivity between histone fraction 2 and myelin basic protein is provided by the work of Coates and Carnegie (1975) . They showed that the histone fraction was unable to elicit transformation of guinea-pig lymphocytes sensitized to tumour basic protein although tumour and myelin basic protein would produce significant transformation. It is difficult to reconcile these conflicting reports, but variation in the composition and purity of the histone fraction could account for some non-reactivity since some histone fractions are relatively inactive (Johns et al., 1973) . Previous reports (e.g. Whittingham et al., 1972) of antibodies to myelin basic protein cross-reacting with histones probably reflect the degree of histone contamination in the immunizing protein rather than antigenic identity. Strong evidence in support of the contention that basicity is not the only requirement for activity is our finding that the tryptophane peptide of myelin is effective in producing positive responses with cancer patients. The tryptophane peptide derivative of myelin basic protein is neutral at physiological pH, but still retains the stimulatory activity of the parent basic protein. In this context, further evidence that an immunological recognition event is operating independently of electrical charge is provided by Carnegie, Caspary and Field (1973a) who showed that blocking tryptophane activity of myelin basic protein with Koshland's reagent markedly reduced its effectiveness in the MEM test without affecting the overall charge. The inactivity of basic proteins other than myelin and tumour basic protein in the MEM test does not pre-empt a function for charge effects in lymphocyteantigen recognition, but indicates that antigenic specificity plays a determining role. That charge effects may be important in T-cell recognition of antigens is indicated by the recent report of Teitelbaum et al. (1975) , who showed that thymocytes with specificity for negatively charged antigens could be depleted on positively charged columns, and vice versa. These investigators found that the thymocytes depleted on the columns performed the full range of T-cell functions, including T helper-cell cooperation and cell-mediated immune responses of the delayed hypersensitivity type. In conclusion, our finding that basic proteins, other than tumour basic protein, and the tryptophane peptide of myelin basic protein were unable to elicit positive MEM responses strengthens the concept that the test is monitoring an antigenic recognition event, and enhances its validity as a sensitive indicator of immune response to tumour antigens.
